Vaccinex VCNX
OTC VCNX
$0.69 -0.02 (-2.16%)
As of: Oct 21, 2026 · 10:31 AM EDT

Vaccinex, Inc. (VCNX) Capital Expenditures (2017 - 2024)

Updated

Vaccinex's Capital Expenditures was $22,000 in FY2024, down 67.2% from $67,000 in FY2023.

Analysis

Vaccinex, Inc. (VCNX) Capital Expenditures (2017 - 2024) Analysis & Trends

From FY2017 onward, Vaccinex has reported Capital Expenditures for 8 years.

  • Capital Expenditures shows a five-year compound annual growth rate of -22.4% (FY2019 to FY2024).
  • The FY2024 figure marks the lowest annual Capital Expenditures in data going back to FY2017.
  • Per Business Quant data, Capital Expenditures in earlier years was $67,000 in FY2023 (-32.3%), $99,000 in FY2022 (+209.4%), $32,000 in FY2021 (-89.0%) and $290,000 in FY2020 (+271.8%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 8,000.00
Jun 30, 2024 14,000.00
Sep 30, 2023 18,000.00
Mar 31, 2023 49,000.00
Dec 31, 2022 -2,000.00
Sep 30, 2022 49,000.00
Sep 30, 2021 10,000.00
Dec 31, 2020 -1,000.00
Sep 30, 2020 37,000.00
Mar 31, 2020 254,000.00
Dec 31, 2019 1,000.00
Sep 30, 2019 10,000.00
Dec 31, 2018 169,000.00
Sep 30, 2018 5,000.00
Jun 30, 2018 14,000.00
Mar 31, 2018 47,000.00
Dec 31, 2017 3,000.00
Sep 30, 2017 8,000.00
API Access

Vaccinex, Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VCNX&period=max&api_key=YOUR_API_KEY